BeStock  
Markets › Compare › NVAX vs BCRX

NVAX vs BCRX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NVAX · Novavax$12.56 ▲ 20.08%
BCRX · BioCryst Pharmaceuticals$8.10 ▼ 0.86%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

6288114140165Oct 7, '25Apr 7, '26Oct 5, '26
  • NVAX +36.2%
  • BCRX +16.5%

Head to head

MetricNVAXBCRX
Price$12.56$8.10
Change today▲ 20.08%▼ 0.86%
Market cap$2.07B$2.07B
Return, 3 months+32.8%-26.3%
Return, year to date+86.9%+3.8%
Return, 1 year+38.3%+15.4%
P/E (TTM)-9.3-5.8
P/B-10.9-4.6
P/E percentile vs own 5y10th74th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price-9.8%+141.6%
Analyst buy share33%71%
RSI (14)7735
30-day volatility70.3%41.1%
Max drawdown, 1 year-34.9%-27.1%
Trend readStrong uptrendStrong downtrend
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NVAX is the largest of the group by market value.
  • NVAX has returned the most over the past year.
  • NVAX carries the lowest trailing P/E.
  • BCRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top